Novel Pharmacological Interventions for Alcoholism edited by Claudio A. Naranjo, Edward M. Sellers.
Saved in:
| 企业作者: | |
|---|---|
| 其他作者: | , |
| 格式: | 电子书 |
| 语言: | English |
| 出版: |
New York, NY :
Springer New York : Imprint: Springer,
1992.
|
| 版: | 1st ed. 1992. |
| 丛编: | Springer eBook Collection.
|
| 主题: | |
| 在线阅读: | Click to view e-book |
| Holy Cross Note: | Loaded electronically. Electronic access restricted to members of the Holy Cross Community. |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | b3223098 | ||
| 003 | MWH | ||
| 005 | 20191027141206.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 121227s1992 xxu| s |||| 0|eng d | ||
| 020 | |a 9781461228783 | ||
| 024 | 7 | |a 10.1007/978-1-4612-2878-3 |2 doi | |
| 035 | |a (DE-He213)978-1-4612-2878-3 | ||
| 050 | 4 | |a E-Book | |
| 072 | 7 | |a MMH |2 bicssc | |
| 072 | 7 | |a MED105000 |2 bisacsh | |
| 072 | 7 | |a MKL |2 thema | |
| 245 | 1 | 0 | |a Novel Pharmacological Interventions for Alcoholism |h [electronic resource] / |c edited by Claudio A. Naranjo, Edward M. Sellers. |
| 250 | |a 1st ed. 1992. | ||
| 264 | 1 | |a New York, NY : |b Springer New York : |b Imprint: Springer, |c 1992. | |
| 300 | |a XV, 378 p. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Springer eBook Collection | |
| 505 | 0 | |a I. General Methodologic Issues -- 1. Animal Models for Testing Drug Effects on Alcohol Consumption -- 2. Animal Models for Screening Drugs to Decrease Alcohol Consumption -- 3. Medications for Alcohol Abuse and Dependence: Methodology for Clinical Studies -- 4. Some Issues in the Evaluation of a Pharmacotherapy of Alcoholism -- II. Serotonin and Alcohol Consumption -- 5. Serotonin and Alcohol Consumption -- 6. Serotonergic and Dopaminergic Involvement in Ethanol Intake -- 7. Serotonin and Alcohol Consumption -- 8. Basic and Clinical Studies on Serotonin, Alcohol, and Alcoholism -- 9. Evaluation of the Effects of Serotonin Uptake Inhibitors in Alcoholics: A Review -- III. Opioids and Alcohol Consumption -- 10. Opioids Modulate Rats’ Propensities to Take Alcoholic Beverages -- 11. The Enkephalinergic System and Maintenance of Ethanol Drinking -- 12. The Relationship of Alcohol Drinking and Endogenous Opioids: The Opioid Compensation Hypothesis -- 13. Naltrexone in the Treatment of Alcohol Dependence: Preliminary Findings -- IV. The Role of Other Neurotransmitters in Regulating Alcohol Intake -- 14. Neurotransmitter Systems Regulating Alcohol Intake -- 15. Agents Which Modify Channels as Potential Treatments in Alcohol Withdrawal -- 16. Management of Alcohol Consumption with Angiotensin Converting Enzyme Inhibitors: A Review of the Animal Findings -- 17. Enalapril Does not Decrease Alcohol Intake in Normotensive Alcoholics -- Poster Papers -- General Methodologic Issues -- Rational vs. Reflexive Alcohol Drinking -- Rats’ Intakes of Different Alcoholic Beverages -- Drug-induced Specific and Nonspecific Changes in Voluntary Ethanol Intake by Rats -- Rationale for Alcoholism Treatment Based on Inhibition of Aldehyde Dehydrogenase -- The Effect of Low Alcohol Beverages on Alcoholism Levels in Canada in 1986 -- Alcoholism, Antisocial Behavior, and Family History: A Synopisis -- Perception of Whether Drug or Placebo has been Administered is a Determinant of Drinking Reduction -- Disulfiram Treatment of Alcoholism -- Controlled Release Disulfiram (DS) Implant -- Depot Disulfiram: Pharmacokinetics and Clinical Effects During 28 Days Following a Single Subcutaneous Dose -- Mildly Intoxicating Levels of Alcohol Produces Direct Myocardial Depression on Left Ventricular Performance -- A Human Model for Testing Drug-induced Concomitant Variations in Alcohol Consumption and Desire to Drink -- Serotonin and Alcohol Consumption -- Mianserin, a Serotonergic Antagonist, and Intake of an Alcoholic Beverage -- Effects of the 5-HT Uptake Inhibitor, Sertraline, on Ethanol, Water and Food Consumption -- Fluvoxamine is Poorly Tolerated by Alcoholics -- Opioids and Alcohol Consumption -- Effects of Differential Handling on Rats’ Intake of Alcohol -- Stereoselectivity of Opioids’ Effects on Intake of an Alcoholic Beverage -- Metabolites of Morphine and Intake of an Alcoholic Beverage -- Peripheral Administrations of TIQS and Intake of an Alcoholic Beverage -- Morphine Enhances Intake of an Alcoholic Beverage Regardless of Type of Flavoring -- LY78335, an Inhibitor of Phenylethanolamine N-methyltransferase, and Rats’ Intake of an Alcoholic Beverage -- LY255582, an Opioid Antagonist, and Intake of an Alcoholic Beverage -- Effects of Naltrexone on the Cognitive Functioning of Recently Abstinent Alcohol Dependent Patients -- The Role of Other Neurotransmitters in Regulating Alcohol Intake -- Calcium-diacetyl-homotaurinate which Prevents Relapse in Weaned Alcoholics Decreases the Action of Excitatory Amino Acids in Neocortical Neurons of the Rat in Vitro -- THC, an Active Ingredient in Marijuana, and Rats’ Intake of a Sweetened Alcoholic Beverage -- Cocaine and Rats’ Intake of an Alcoholic Beverage -- Calcium-acetylhomotaurinate for Maintaining Abstinence in Weaned Alcoholic Patients: A Placebo-controlled Double-blind Multicenter Study -- Effects of Angiotensin Converting Enzyme Inhibitors on Free Choice Ethanol Consumption by Rats -- Calcium Channel Antagonists Attenuate the Alcohol Dependence Syndrome -- Pharmacological Antagonism of Ethanol by Dl-?-tocopherol -- Characterization of DSM-IIIr Criteria for Uncomplicated Alcohol Withdrawal: Proposal for a Diagnostic Inventory and Revised Withdrawal Scale -- Ethanol Effects of CNS Dopamine Receptors: In vivo Binding Following Voluntary Ethanol (ETOH) Intake in Rats -- Closing Remarks -- Author Index. | |
| 520 | |a Novel Pharmacological Interventions for Alcoholism identifies priorities for focusing alcoholism and addiction research efforts during the coming years. A number of important issues concerning methodology, mechanisms, clinical evaluation, and pharmaceutical aspects are discussed. This book is also a plea for a greater degree of collaboration among academics, pharmaceutical physicians and scientists, and drug regulators; it demonstrates that progress in understanding and fighting addiction and alcoholism is possible in the foreseeable future. | ||
| 590 | |a Loaded electronically. | ||
| 590 | |a Electronic access restricted to members of the Holy Cross Community. | ||
| 650 | 0 | |a Psychiatry. | |
| 650 | 0 | |a Psychology. | |
| 650 | 0 | |a Pharmacology. | |
| 690 | |a Electronic resources (E-books) | ||
| 700 | 1 | |a Naranjo, Claudio A. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Sellers, Edward M. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer eBooks | |
| 830 | 0 | |a Springer eBook Collection. | |
| 856 | 4 | 0 | |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-1-4612-2878-3 |3 Click to view e-book |t 0 |
| 907 | |a .b32230989 |b 04-18-22 |c 02-26-20 | ||
| 998 | |a he |b 02-26-20 |c m |d @ |e - |f eng |g xxu |h 0 |i 1 | ||
| 912 | |a ZDB-2-SME | ||
| 912 | |a ZDB-2-BAE | ||
| 950 | |a Medicine (Springer-11650) | ||
| 902 | |a springer purchased ebooks | ||
| 903 | |a SEB-COLL | ||
| 945 | |f - - |g 1 |h 0 |j - - |k - - |l he |o - |p $0.00 |q - |r - |s b |t 38 |u 0 |v 0 |w 0 |x 0 |y .i21362634 |z 02-26-20 | ||
| 999 | f | f | |i 46307b7c-84d9-5de7-a2a7-bdc1fad0b434 |s 590a8526-9812-50ad-b310-fb35f609d3e1 |t 0 |
| 952 | f | f | |p Online |a College of the Holy Cross |b Main Campus |c E-Resources |d Online |t 0 |e E-Book |h Library of Congress classification |i Elec File |